Recent studies have clarified that activated neutrophils in pancreatic ductal adenocarcinoma patients release NETs, where arginase 1 (ARG1) interacts with cathepsin S to obtain enzyme activity, thereby exerting anticancer effects (81). The gene discussed is ARG1; the disease is pancreatic ductal adenocarcinoma.